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Neonatal T lymphocyte tolerance to proteins has been extensively studied, but
the underlying mechanisms are still unknown (1-3). One hypothesis is that
tolerance is due to the inactivation ofTcells on contact with antigen at an early
stage of development. Alternatively, tolerance may be the result of the stimula-
tion of other T cells, which actively suppress subsequent responses. We have
developed a novel experimental system using peptides to analyze the tolerant
state at the level of individual peptide determinants, and to detect functional
suppression. This approach makes use of the finding that different T cell
subpopulations appear to recognize different determinants (4, 5). Thus, Ts
specific for a distinct determinant(s) on a protein molecule suppress the response
of T cells specific for other regions ofthe molecule. Although the mechanism of
this antigen-bridging suppression is poorly understood, the ability of Ts to act
across an antigen bridge has been confirmed experimentally by the coupling of
Ts-inducing determinants (SD) to those recognized by the responding T cells (6,
7). Further, proliferative T cells (Tp) can be stimulated, despite the presence of
Ts, by fragments of the whole protein that bear the Tp-inducing determinant
but lack the Ts-inducing determinant (8). Peptides lacking a suppressor deter-
minant can be used as probes to reveal latent responses in tolerant mice, i.e.,
responses not induced by challenge with the whole molecule. Previously (9), we
showed that neonatal tolerance can be induced by small synthetic cytochrome c
peptides. In that system, the specificity oftolerance matched that ofthe response
to the peptide, providing evidence for direct clonal inactivation. In this report,
we show that the induction of tolerance to one determinant on a 23-amino acid
peptide does not affect the response to a second determinant on the same
peptide, as would be predicted in a suppressor model. Furthermore, the congru-
ence of minimal immunogenic and tolerogenic peptides is demonstrated.
Materials and Methods
Mice.
￿
B10.A mice were obtained from TheJackson Laboratory, Bar Harbor, ME, and
bred at our facility. Mice ofeither sex were used at 8-12 wk ofage.
Antigens. The synthetic peptides shown in Table I were prepared by solid-phase
peptide synthesis, as described (10).
Neonatal Tolerance Induction.
￿
Neonatal B10.A mice received a single intraperitoneal
injection of 14 nmoles of peptide in 0.05 ml of a saline emulsion with IFA (Gibco
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Synthetic
peptide
TABLE I
SyntheticHEL Peptides Used to Study Tolerance
Amino acid residues of HEL
T11(74-96) N L C N I P C S A L L S S D I T A S V N C A K
85-96
￿
- - - - - - - - - - -
74-86
￿
------- ------
74-82 ---------
77-86 ----------
Laboratories, Grand Island, NY) at 24-48 h after birth . Tolerance was induced to the
peptides 74-82 and 77-86 by two intraperitoneal injections of 7 nmoles of peptide in IFA,
the first between 24-48 h and the second between 72-96 h after birth . Control mice
were normal age- and sex-matched B10.A mice . We had found earlier (our unpublished
data) that injection of saline/IFA emulsion into neonatal mice does not affect subsequent
proliferative responses to peptides in adult mice .
Immunizations .
￿
8-12-wk-old mice were injected in each rear footpad with 3 .5 nmoles
of peptide in a saline emulsion with CFA containing 1 mg/ml Mycobacterium tuberculosis
strain H37Ra (Difco Laboratories, Detroit, MI) .
In Vitro Proliferation Assay.
￿
The in vitro culture system has been described previously
(11) . Inguinal and popliteal lymph nodes were removed 9-11 d after immunization, and
single-cell suspensions were prepared . 4 x 105 cells were cultured in 96-well microtiter
plates in 200 ,,1 of supplemented Click's medium . Tuberculin PPD (Connaught Labora-
tories, Ltd., Willowdale, Canada) was used as a positive control for each mouse, at a final
concentration of 5 Ag/ml . The cultures were incubated at 37 °C in 2% C02 and 98% air
for 5 d . Proliferation was assayed by addition of 1 UCi [ 5H]thymidine (sp act 33 Ci/mmol ;
International Chemical and Nuclear, Irvine, CA) for the last 18 h of the culture, and
incorporation of label was measured by liquid scintillation counting .
Results
BIO.A Response to TI1 .
￿
Immunization of adult B10 .A mice with the synthetic
peptide T11, which corresponds to amino acid residues 74-96 of hen eggwhite
lysozyme (HEL), induces a strong in vitro proliferative response . Analysis of T
cell clones derived from three TI I-specific lines has revealed the presence of
distinct determinants contained within the smaller peptides 74-86 and 85-96 (10
andour unpublished results) . All the clones obtained responded either to peptide
74-86 or 85-96, as well as to T11 . Thus, there are at least two determinants on
T1 1, and both peptides 74-86 and 85-96 recall in vitro proliferation in T I 1-
primed lymph node cells (Table II) . Interestingly, T 11 is much more efficient in
stimulating an in vitro proliferative response than the smaller peptides, (i.e ., the
sum of the responses to the two smaller peptides does not equal the T 11
response) . Although this could be due to the presence of T cells specific for a
third determinant on T 11, the evidence from the analysis of the T cell lines
argues against this . Changes in the relative ability of peptides of varying lengths
to recall a response in vitro has been observed previously (12), and may reflect
the ability of the different peptides to maintain a stable secondary structure
under these culture conditions .
Induction of Tolerance with TI I (peptide 74-96).
￿
To investigate the underlying
mechanism of neonatal tolerance to HEL peptides, neonatal B10.A mice were
injected with T11 in an IFA emulsion at 24-48 h after birth . Challenge withGAMMON ET AL.
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TABLE II
Responses of T11- and 74-86-tolerant Mice
Normal, and TI 1- and 74-86-tolerant mice were challenged with peptide in CFA at 8-10 wk of age. The in vitro
proliferative response was measured by ['H]thymidine incorporation, and the values shown are the average of the
responses of six or seven individual mice ± SE. Background (medium alone) has been subtracted.
TI I in CFA at 8-10 wk ofage showed that these mice were profoundly tolerant
(Table II, line b). There was no significant response in vitro to T11, 74-86, or
85-96 after in vivo TI I challenge. Totest for latent responsiveness to the peptide
74-86, T1 I-tolerant mice were challenged with 74-86 in CFA. No response was
observed (Table II, lines c and d). The failure of T11-tolerant mice to respond
to challenge with 74-86 could only be due to suppression if 74-86 fortuitously
contained a Ts-inducing determinant (SD) in addition to a Tp-inducing deter-
minant (PD). This seems unlikely given the small size (13 amino acids) of the
peptide. Nevertheless, this possibility can be tested by examining the effect of
74-86-induced tolerance on the response to the neighboring determinant within
the sequence 85-96 on T11.
Specificity of Tolerance to 74-86.
￿
The possibility that Ts specific for 74-86
exist in mice tolerant to 74-86 was tested by inducing tolerance to this peptide
and then challenging with T11-CFA. As discussed earlier, these are many
examples of Ts acting via an antigen bridge to suppress the response to linked
determinants. Thus, 74-86-specific Ts should also act on Tp responding to the
C-terminal determinant on TI 1 and suppress the response to both determinants
on T11. On the other hand, iftolerance were due to clonal inactivation, it would
be restricted to epitopes on the tolerogen, and the response to linked determi-
nants would be unaffected. Therefore, in this example, 74-86-tolerant mice
should respond to the determinant on peptide 85-96 after challenge with T11.
Mice injected with 74-86 between 24 and 48 h after birth were tolerant to
later challenge with 74-86 (Table II, lines c and e). Challenge with TII-CFA
stimulated a response that was limited to 85-96, and which was ofapproximately
equal strength to the control response (Table II, compare lines a andf). Thus,
74-86 induces tolerance to itself only, and the response to the C-terminal
determinant on TI I was unaltered. This result is further evidence against
suppression and hence support for clonal inactivation. It is conceivable that 74-
86 induces Ts that are functionally restricted and can only suppress the 74-86
response and not the response to the other determinant within T11 . Although
we considered this unlikely, we could not discount it, so we sought further
evidence against active suppression by using the smaller constituent peptides 74-
82 and 77-86.
Tolerance Induction Using Minimal Peptides.
￿
If tolerance were the result of
['H]Thymidine incorporation (Acpm x 10-')
Line Tolerogen Immunization Medium
alone T11(74-96) 74-86 85-96 PPD
a - TI1 4.9 61 .9±6.7 9.6±2.2 17.5±4.1 83.8±3.9
b T11 T11 6.3 3.9 ± 1.0 1 .8 ± 0.6 3.7 ± 0.8 90.6 ± 7.2
c - 74-86 3.7 13.7 ± 1.6 13.9 ± 1.2 - 46.5 ± 2.6
d T11 74-86 3.4 2.2 ± 0.5 1 .2 ± 0.7 - 51.3 ± 2.6
e 74-86 74-86 3.5 1 .8 ± 0.5 1 .7 ± 0.6 - 48.7 ± 3.9
f 74-86 T11 7.5 39.5±7.3 1 .5±0.7 16.5±4.8 94.9±5.1670
￿
GAMMON ET AL.
￿
BRIEF DEFINITIVE REPORT
Exp. Medium
alone
Tolerogen
TABLE III
Specificity ofResponse to 74-86
['H]Thymidine incorporation (Ocpm X 10-')
T11 74-86 74-82 77-86 PPD
1
￿
2.7
￿
36.9 ± 1 .3
￿
20.6 ± 3.9
￿
22.4 ± 3.1
￿
1 .2 ± 0.2
￿
96.2 ± 3.0
2
￿
4.3
￿
41.3 ± 2.6
￿
29.5 ± 4.4
￿
17.2 ± 3.2
￿
0 ± 0.2
￿
98.2 ± 5.2
Popliteal and inguinal lymph nodes from three normal B10.A mice immunized with 74-86 were pooled, and the in
vitro proliferative response to medium alone, to 5 ug/ml PPD, and to 7 wM T11, 74-86, 74-82, and 77-86, was
measured. The values shown are the average o£ triplicate wells ± SE.
TABLE IV
Response to HEL Peptide 74-86 after Neonatal Injection with 74-82
or 77-86
['H]Thymidine incorporation per culture (Acpm X 10-')
Medium alone
￿
74-86
￿
PPD
-
￿
3.7 20.2±6.1 137 .4±11 .9
74-82
￿
2.5
￿
4.7 ± 2.0
￿
157.3 ± 10.4
77-86
￿
2.0
￿
31 .3 ± 6.7
￿
142.8 ± 8.6
The in vitro proliferative response of peptide 74-86-primed lymph node cells to
medium alone, PPD (5 fag/ml), and 74-86 (14 uM) was assayed. The values shown
are the mean of the responses of seven or eight individual mice ± SE.
clonal inactivation, exactly the same peptides that stimulate a response should be
able to induce tolerance. However, if tolerance were due to active suppression,
the critical requirement for the induction of tolerance by a peptide would be
that it contained a Ts-inducing determinant; any peptide lacking an SD would
not be tolerogenic, but could be immunogenic. Alternatively, a peptide could be
tolerogenic, containing an SD, but could lack a Tp-inducing determinant (PD),
and be nonimmunogenic. The use of peptides smaller than the 13-amino acid
74-86 might fortuitously separate the PD and the putatively overlapping SD. To
test this hypothesis, we used the TI 1 amino-end peptides, 74-82 and 77-86. 74-
82 can stimulate in vitro proliferation in 74-86-immunized lymph node cells
(Table 111), while 77-86 does not (but mightconceivablycontainan SD). Neonatal
mice were injected with 74-82 or 77-86, and challenged at 8 wk with 74-86. 74-
82 induced tolerance to 74-86, while 77-86 had no effect on the subsequent
response (Table IV). Thus, the ability to induce tolerance correlated precisely
with the ability to stimulate a response; even a nine-amino acid peptide, near
the minimal size reported for an immunogenic peptide (12), could induce
neonatal tolerance.
Discussion
The crux ofthis approach to the study of tolerance induction is the separate
analysis of clonal inactivation and suppression, taking advantage of two general
findings: (a) that T suppressor cell-inducing and T-helper/proliferatioe cell-
inducing determinants are distinct and nonoverlapping, and (b) that Ts effects
can be expressed both on nearby and distinct determinants, while clonal inacti-
vation can only affect T cells directed at the determinants on the tolerogen.GAMMON ET AL.
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Furthermore, the possibility of a peptide containing both an SD and a PD
becomes increasingly remote as smallerpeptides are used, so that at the level of
minimal immunogenic peptides, the only remainingmechanisms tobe considered
are those involving clonal inactivation.
Administration of the peptide 74-86 to neonatal mice induces tolerance to
itself. However, this tolerance does not affect the independent response to 85-
96 when the tolerant mouse is injected with 74-96, a situation in which putative
Ts within 74-86 should have been able to influence the response to the neigh-
boring peptide. BlO.A mice can respond to many different peptides from
lysozyme, but Ts directed against the N-terminal determinant of HEL can turn
off the antibody response or the proliferative response to the whole molecule
(15), including that to a nearby determinant.
These experiments indicated that no SD was contained within 74-86, but to
test the possibility that an overlapping SD might exist within the tridecapeptide,
we tried, and were able to use the smallest immunogenic peptide 74-82 to induce
tolerance. To see whether the unnecessary 83-86 stretch might have included
useful Ts-inducing residues, we used 77-86 to try to induce tolerance for 74-86;
it did not. In conclusion, the smallest immunogenic peptide also could induce
tolerance, virtually excluding any other situation than one in which the minimal
immunogenic peptide and the putative minimal suppressogenic peptide were
exactly congruent. Further, the suppressive effect in this presumptive case must
be very circumscribed, as the response to the nearby determinant contained
within 85-96 was unaffected. Such congruent suppression has yet to be demon-
strated directly.
As well as antigen-specific Ts, Ts recognizing the idiotypy of the antigen-
reactive T cell must be considered a possible mechanism oftolerance. These Ts
would act directly on the Tp, recognizing idiotopes on the T cell receptor and
suppressing activation. However, there is little evidence for such Ts in neonatal
tolerance to proteins, and we were unable to show any Ts in cell mixing
experiments using an in vitro suppressor assay in cytochrome c-tolerant mice
(13). To assess a possible role for Ts, we have commenced studies in neonatal
tolerance using anti-suppressor cell or antifactor mAbs to see to what extent, if
any, the pattern oftolerance induction is affected.
Summary
To investigate the mechanism underlying neonatal T cell tolerance, we used
synthetic peptides to induce tolerance. We found that induction of tolerance to
one determinant on a 23-amino acid peptide did not affect the response to an
adjacent determinant on the same peptide. There was no evidence ofsuppression
of the response to the second determinant. Furthermore, even small peptides
near the minimal size for a determinant, which would be very unlikely to possess
a suppressor T cell-inducing determinant as well as a proliferative T cell-
inducing determinant, could induce tolerance. These studies provide in vivo
experiments supporting clonal inactivation as the mechanism of neonatal toler-
ance to immunogenic peptides.
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